Abnormal expression of Zeb2 protein in epithelial cells can induce colorectal cancer
A collaborative study by research groups from the VIB-UGent Center for Inflammation Research and Ghent University uncovered a new mechanism causing colorectal cancer.
Wastewater should be improved to eliminate antibiotic resistance, says Örebro University expert
Over a three-year period, Faisal Ahmad Khan and his fellow researchers have taken samples from various sites along the River Svartån and in the Lake Hjälmaren – including both upstream and downstream the river from the city centre; in Hemfjärden where the river flows into the lake; as well as in the water by the treatment plant in Örebro.
Prolonged exposure of the head to sunlight impairs motor-cognitive performance
Approximately half of the global population live in regions where heat stress is an issue that affects the ability to live healthy and productive lives.
Awareness campaign aims to alleviate unnecessary fears about calling 9-1-1 in pandemic
As new COVID-19 cases continue to rise in 22 states and strain emergency departments nationwide, the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) suggest ER visits in April were down 42% across the country compared to the same period last year.
Yale researchers discover the cause for sudden onset of OCD in children
Yale scientists may have found a cause for the sudden onset of obsessive-compulsive disorder (OCD) in some children, they report.
New wearable patch may provide improved treatment experience for melanoma patients
Conventional melanoma therapies, including chemotherapy and radiotherapy, suffer from the toxicity and side effects of repeated treatments due to the aggressive and recurrent nature of melanoma cells.
Life Saving Drug Found for COVID-19 Patients on Ventilators
Results from Oxford University’s RECOVERY trial into existing drugs for the treatment of COVID-19 has found that dexamethasone reduced deaths by a third in ventilated coronavirus patients and by a fifth in coronavirus patients requiring oxygen. This is the first drug of its kind to be demonstrated to have a significant impact on COVID-19 mortality.
Wealthy hospital taps small craft breweries for financial aid to buy masks, gloves
As Inova Health System sought donations in March to buy personal protective equipment for its staff to treat COVID-19, Zach Mote, a police officer turned brewer, came to their aid.
Study: Gender dysphoria can persist for years before patients undergo treatment
Gender dysphoria manifests early in childhood and can persist for years before patients undergo counseling and treatment, a Cedars-Sinai study has found.
Health experts link rise in Arizona COVID cases to end of stay-at-home order
With new daily coronavirus cases rising in at least two dozen states, an explosion of new infections in Arizona is stretching some hospitals and alarming public health experts who link the surge in cases to the state’s lifting of a stay-at-home order a month ago.
Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19
Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.
Why improved pneumonia diagnosis is needed now more than ever
News-Medical speaks to Dr. William La Via about why improved pneumonia diagnosis is vital, especially in the wake of the COVID-19 pandemic.
Cell signaling pathway could treat chronic kidney disease and other medical conditions
Scientists have discovered an important cell signaling pathway in the kidney which if stopped, could hold the key to treating chronic kidney disease as well as other deadly conditions, including heart attack and stroke.
Study highlights processes that act as barriers to use evidence-based pulmonary embolism testing
Common barriers exist to the use of risk stratification tools in the evaluation of pulmonary embolism in the emergency department and provide insight into where to focus efforts for future implementation endeavors.
COVID-19 health crisis highlights food insecurity among children
One in four households with children have reported a child experiencing hunger as a result of the COVID-19 health crisis, according to the latest CUNY SPH COVID-19 tracking survey.
Study: High folate levels increase the risk of poor cognition in older adults
A new study led by researchers from The Irish Longitudinal Study on Ageing (TILDA) at Trinity College Dublin challenges claims from some international scientific circles, that having high blood levels of folate (folic acid) increases the risk of poor cognition in older adults, especially in those with low levels of vitamin B12.
Study: Biomarkers are needed to support the diagnosis of frontotemporal lobar degeneration
Biomarkers to support the diagnosis of frontotemporal lobar degeneration (FTLD) and to assess the severity and expected prognosis of the disease are needed.
New mapping tool details SNAP policies related to food shopping during the pandemic
The complex food shopping patterns that financially insecure families employ have been upended by the COVID-19 crisis.
Link between ALS and Alzheimer's disease can help advance the search for new therapies
On the surface, amyotrophic lateral sclerosis (ALS) and Alzheimer's disease share two commonalities: Both are progressively debilitating neurodegenerative conditions--meaning symptoms get worse--and, at least for now, neither has an effective treatment, let alone a cure.
Many Americans face high out-of-pocket medical costs for COVID-19 hospitalizations
If past hospitalizations for pneumonia and other respiratory illnesses are any guide, many Americans could face high out-of-pocket medical costs for COVID-19 hospitalizations despite the fact that many insurers have waived their cost-sharing requirements, a study from researchers at Johns Hopkins Bloomberg School of Public Health suggests.
No hay comentarios:
Publicar un comentario